Pfizer can do for cancer what it has done for COVID-19 ‘by using another novel technology,’ CEO Albert Bourla says
Pfizer plans to acquire Seagen, which develops cancer treatments. (Photo by Spencer Platt/Getty Images
Getty Images
Pfizer’s PFE proposed acquisition of Seagen SGEN, which develops cancer treatments, for $43 billion indicates that the legacy drugmaker is focused on shoring up its oncology business.
Pfizer said Monday it plans to pay $229 per share in cash for Seagen, whose stock soared more than 15% in trading on Monday afternoon. Pfizer’s shares gained about 1.7%.
“[Seagen’s]…
